In the performance report, EVEREST MED's annual loss narrowed to 298 million RMB, and no dividend will be distributed
EVEREST MED (01952.HK) announced its full-year results for the year ended December last year, with a revenue of RMB 1.707 billion, an increase of 141.5% year-on-year. The loss narrowed to RMB 298 million, compared to a loss of RMB 1.041 billion in the same period last year; the loss per share was RMB 0.89. No dividend was declared
Source: AASTOCKS The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments